Research Paper Volume 16, Issue 15 pp 11729—11743

Hsa-miR-181a-2-3p inhibits the oncogenicity of colon cancer by directly targeting STING

class="figure-viewer-img"

Figure 1. miR-181a-2-3p is lowly expressed in colon cancer. (A) Expression of miR-181a-2-3p in colon cancer compared with normal. (B) Expression levels of miR-181a-2-3p in different stages of colon cancer tissues. (C) The relative expression level of miR-181a-2-3p in different cells was detected by q-PCR. The expression level of normal colon cells (FHC) was set as 1. Note: Figure A and B are based on analysis of TCGA database (http://ualcan.path.uab.edu/index.html). Figure 1A: red is the colon cancer group, and blue is the normal control group. Figure 1B: blue is the normal control group, and the rest are colon cancer tissues at different stages.